Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.40 +0.05 (+3.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Transcode Therapeutics (RNAZ) Other Operating Expenses (2025 - 2026)

Updated

Transcode Therapeutics' Other Operating Expenses was $217,000 in Q2 2026.

Analysis

Transcode Therapeutics (RNAZ) Other Operating Expenses (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Transcode Therapeutics' Other Operating Expenses was $8.89 million through Jun 30, 2026; for FY2025, it came in at -$1.58 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Transcode Therapeutics 1.37 Mn -40.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 217,000.00
Mar 31, 2026 -116,000.00
Dec 31, 2025 8.79 Mn
API Access

Transcode Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RNAZ&period=max&api_key=YOUR_API_KEY